347 related articles for article (PubMed ID: 16508970)
1. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.
Wen T; Li Y; Wu M; Sun X; Bao X; Lin Y; Hao J; Han L; Cao G; Wang Z; Liu Y; Wu Z; Hong Z; Wang P; Zhao L; Li Z; Wang Q; Yin Z
Arthritis Rheum; 2012 Sep; 64(9):2896-906. PubMed ID: 22576707
[TBL] [Abstract][Full Text] [Related]
3. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
9. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
10. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
11. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
12. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
[TBL] [Abstract][Full Text] [Related]
13. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
15. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
[TBL] [Abstract][Full Text] [Related]
19. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
Ross AD; Banda NK; Muggli M; Arend WP
Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
